Mark Identification

COSUNTER

Serial Number

98731337

Filing Date

Sep 3, 2024

Trademark by

FUJIAN COSUNTER PHARMACEUTICAL CO. LTD.

Classification Information

Nutritive substances for microorganisms for medical purposes; Medicines made of Chinese traditional medicinal herbs, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Medicines for human purposes, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Drugs for medical purposes, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Pharmaceutical preparations, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Crude drugs, namely, medicines, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Biochemical medicines, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Medicinal tea; Dietetic foods and beverages adapted for medical use; Dietetic preparations adapted for medical purposes.

Pharmaceuticals